Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982 Aug;108(2):171-83.

Characterization of three macrophage chemotactic factors from PPD-induced delayed hypersensitivity reaction sites in guinea pigs, with special reference to a chemotactic lymphokine

Affiliations

Characterization of three macrophage chemotactic factors from PPD-induced delayed hypersensitivity reaction sites in guinea pigs, with special reference to a chemotactic lymphokine

M Honda et al. Am J Pathol. 1982 Aug.

Abstract

Three types of macrophage chemotactic factors (MCFs) were separated from purified protein derivative (PPD)-induced delayed hypersensitivity (DHR) skin lesions in guinea pigs, and MCF-c was purified isotachophoretically. The macrophage chemotactic activity (MCA) of the skin extract was mostly associated with MCF-a and c. MCF-c (mol wt 110,000) seemed more significant for mediating the macrophage reaction than MCF-a (mol wt 150,000), which exhibited common antigenicity with serum IgG. MCF-b (mol wt 14,000), manifesting common antigenicity with the fifth component of complement (C5), was apparently less significant. MCF-c was thermostable and had an isoelectric point (pI) of 5.2 +/- 0.1. The protein exhibited marked macrophage chemotactic activities (MCA) but no neutrophil chemotactic, lymphocyte chemotactic, and MIF activity in excess of that in vitro. Selective accumulation of macrophages was observed in response to intradermal MCF-c injection. Our studies suggest that MCF-c at 24-hour skin sites of DHR may exist as specific lymphokine preparations with high potential for monocyte infiltration.

PubMed Disclaimer

References

    1. Immunology. 1971 May;20(5):803-8 - PubMed
    1. Cell Immunol. 1975 Jan;15(1):100-8 - PubMed
    1. J Immunol. 1975 Jan;114(1 Pt 2):274-8 - PubMed
    1. J Immunol. 1975 Jan;114(1 Pt 2):293-9 - PubMed
    1. J Immunol Methods. 1979;25(1):43-8 - PubMed

Publication types

LinkOut - more resources